Outcome for metastatic (M plus ) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): Preliminary results of COG 99701

cited authors

  • Jakacki, R; Burger, P; Zhou, T; Holmes, E; Packer, R; Goldwein, J; Mehta, M; Pollack, I

keywords

  • Life Sciences & Biomedicine
  • Oncology

WoS ID

  • 000455043700326

issue

  • 18